Bluebird Bio, INC.
Based in MA
AI Overview
With $3.5M in lobbying spend across 29 quarterly filings, Bluebird Bio, INC is a significant lobbying presence. Their lobbying covers 3 issue areas. Active from 2019 to 2024.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $570K |
| 2020 | $780K |
| 2021 | $760K |
| 2022 | $140K |
| 2023 | $830K |
| 2024 | $390K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Bluebird Bio, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Pharmacy, Health Issues
Alternative payment models related to novel therapies.
Issues related to the reimbursement of gene therapies; issues related to the Patient Affordability Value and Efficiency Act.
Provide guidance and strategic counsel with regard to regulations and legislation that could impact the gene therapies, drug pricing and other issues that impact the industry generally, and bluebird b
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.